Joshua Fitch, Senior Editor

Lauren Streicher, MD, advocates for practical, individualized solutions for postmenopausal sexual dysfunction, emphasizing increased vascularization, stimulation, and addressing related symptoms.

In this video from The Menopause Society Annual Meeting, Lauren Streicher, MD, talks about what to ask your patients about sexual function.

In a recent study presented at the 2024 Annual Meeting of The Menopause Society, insulin resistance was significantly reduced among postmenopausal women receiving hormone therapy vs placebo.

At the 2024 Menopause Society meeting, JoAnn Pinkerton, MD, highlighted phase 3 long-term safety data of elinzanetant from the OASIS 3 trial.

A discussion of vasomotor symptoms and the potential benefits of elinzanetant with Nanette Santoro, MD, from The Menopause Society annual meeting in Chicago, Illinois.

Nanette Santoro, MD, and Lauren Streicher, MD, MSCP, briefly highlight why they feel the annual Menopause Society is a great place for learning and collaboration.

A recent study reveals that consuming fish during pregnancy is associated with a reduced risk of autism in children, while omega-3 supplements show no significant benefit.

In this last episode, our panel discusses this patient population and the challenges around keeping them in the continuum of care.

The CDC's latest guidelines for the 2024 to 2025 influenza season include updates to vaccine composition and specific recommendations for high-risk groups, including children, pregnant persons, and solid organ transplant recipients.

A CDC report shows varying HPV vaccination rates in US-affiliated Pacific Islands, with only some regions on track to meet the 2030 WHO goal.

Expert discussion of several topics including diagnosis, clinical management in older adults, multidrug resistance, and long-acting injectables and PrEP.

The USPSTF found insufficient evidence to assess benefits and harms of screening for iron deficiency and anemia or routine supplementation in pregnancy.

Findings show that that feeding mode is by far the most defining factor for microbial composition," wrote the study authors.

A JAMA Pediatrics study found 37% of adolescents with gender dysphoria began hormone therapy within 2 years, highlighting barriers and inequities in care.

The third and final episode in our series looks at what is in the pipeline as well as a discussion around FDA guidance.

A CDC investigation is underway after a Listeria outbreak, connected to meats sliced at delis, resulted in multiple hospitalizations and fatalities, urging high-risk groups to take precautions.

The second episode in our series looks to address clinical management in a time when antimicrobial resistance appears to be growing.

Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.

Investigating the impact of prenatal vitamin C supplementation on lung function and wheeze occurrence in offspring of pregnant smokers, revealing insights into mitigating respiratory risks.

Discover how maternal tobacco usage during pregnancy affects memory and language skills in children aged 9 to 12 years, as revealed by a comprehensive cohort study.

Samantha Olson, MPH, highlights how maternal vaccination protects infants from influenza.

A recent study found that in utero exposure to maternal COVID-19 vaccination poses no increased risk for neurodevelopmental impairment in infants up to 18 months of age, addressing concerns about the impact of vaccine exposure on unborn children.

In the third installment of RSV Roundtable, our panel discusses the impact nirsevimab has had this RSV season.

In the second installment of RSV Roundtable, our panel explains how they are educating patients and parents when it comes to RSV, vaccines and preventive measures, and limited treatment availability.

A 755% increase in reported cases since 2012 highlights the need for timely testing and treatment to prevent maternal and infant health risks.

The combination vaccine candidates demonstrated a safety profile consistent with Pfizer’s COVID-19 vaccine. A phase 3 trial is anticipated to commence in the coming months, according to a press release from Pfizer.

Mary Jane Minkin, MD, FACOG, MSCP, discusses key takeaways from The Menopause Society 2023 Annual Meeting, held in Philadelphia, Pennsylvania from September 27-30.

Through a randomized, multicenter, open-label, controlled study, investigators determined there were no suggestions of important differences for very preterm infant body composition when comparing an exclusive human milk diet to a diet containing cow milk products.

In collaboration with Contemporary Pediatrics, Contemporary OB/GYN, and Contagion, Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses the benefits of having new tools to fight RSV in infants, potential vaccine hesitancy, and RSV trends currently being observed.

Ahead of the first fall and winter virus seasons in which vaccines are available for COVID-19, influenza, and respiratory syncytial virus (RSV), the Centers for Disease Control and Prevention is recommending Pfizer’s maternal vaccine to protect newborns from severe RSV illness.